117 related articles for article (PubMed ID: 38703794)
1. Intravitreal topotecan for vitreous seeds in retinoblastoma: A long-term review of 91 eyes.
Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
Ophthalmology; 2024 May; ():. PubMed ID: 38703794
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
Rao R; Honavar SG; Sharma V; Reddy VAP
Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
[TBL] [Abstract][Full Text] [Related]
3. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
4. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
5. Vitreous Seed Classification and Regression Patterns in Eyes With Retinoblastoma.
Rishi P; Attiku Y; Manchegowda PT; Agarwal A; Sharma M
J Vitreoretin Dis; 2021; 5(2):121-129. PubMed ID: 37009089
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
[TBL] [Abstract][Full Text] [Related]
7. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
8. Periocular topotecan for vitreous seeds in retinoblastoma.
Sthapit PR; Rao R; Honavar SG
Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
[TBL] [Abstract][Full Text] [Related]
10. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
11. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
12. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma.
Yousef YA; Noureldin AM; Sultan I; Deebajah R; Al-Hussaini M; Shawagfeh M; Mehyar M; Mohammad M; Jaradat I; AlNawaiseh I
J Ophthalmol; 2020; 2020():8628525. PubMed ID: 32047663
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of posterior sub-Tenon's carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds.
Said AMA; Aly MG; Rashed HO; Rady AM
Int J Ophthalmol; 2018; 11(3):445-455. PubMed ID: 29600179
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
16. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma.
Yousef YA; Al Jboor M; Mohammad M; Mehyar M; Toro MD; Nazzal R; Alzureikat QH; Rejdak M; Elfalah M; Sultan I; Rejdak R; Al-Hussaini M; Al-Nawaiseh I
Front Pharmacol; 2021; 12():696787. PubMed ID: 34322023
[No Abstract] [Full Text] [Related]
19. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol.
Amin S; Rizvi F; Zia N; Ali A; Hamid A; Kumari B
Cureus; 2020 Nov; 12(11):e11757. PubMed ID: 33409006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
